Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05805098 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML

Study acronym: VHA
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 7, 2023 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to evaluate the efficacy and safety of venetoclax combined with homoharringtonine and cytarabine in the treatment of newly diagnosed acute myeloid leukemia.
Trial Details
NCT Number NCT05805098
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 Acute Myeloid Leukemia
Related terms Leukemia, Myeloid, Acute
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov